Cite
HARVARD Citation
Karampeazis, A. et al. (2013). Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study. Cancer. 119 (15), pp. 2754-2764. [Online].